Developments in pharmacological therapy for the overactive bladder

被引:9
作者
Chapple, Christopher R.
Gormley, E. Ann
机构
[1] Sheffield Hallam Univ, Dept Urol, Sheffield Teaching Hosp, NHS Fdn Trust, Sheffield 510 2JF, S Yorkshire, England
[2] Dartmouth Hitchcock Med Ctr, Sect Urol, Lebanon, NH USA
关键词
overactive bladder; pharmacotherapy; detrusor overactivity; cholinergic-muscarinic receptors; adrenoceptor; agonist; antagonist; anticholinergics; vanilloids; botulinum toxin; RAT URINARY-BLADDER; QUALITY-OF-LIFE; DETRUSOR SMOOTH-MUSCLE; ANTIMUSCARINIC AGENT SOLIFENACIN; SELECTIVE RECEPTOR ANTAGONIST; EXTENDED-RELEASE FORMULATIONS; CARBACHOL-INDUCED CONTRACTION; BOTULINUM-TOXIN; CONTROLLED TRIAL; AUTONOMOUS ACTIVITY;
D O I
10.1111/j.1464-410X.2006.06381.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:78 / 87
页数:10
相关论文
共 96 条
[61]   Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype [J].
Matsui, M ;
Motomura, D ;
Karasawa, H ;
Fujikawa, T ;
Jiang, J ;
Komiya, Y ;
Takahashi, S ;
Taketo, MM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) :9579-9584
[62]  
Matsui M, 2002, J NEUROSCI, V22, P10627
[63]   Kit positive cells in the guinea pig bladder [J].
McCloskey, KD ;
Gurney, AM .
JOURNAL OF UROLOGY, 2002, 168 (02) :832-836
[64]   Botulinal neurotoxins:: revival of an old killer [J].
Montecucco, C ;
Molgó, J .
CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (03) :274-279
[65]   THE ACTION-POTENTIAL AND NET MEMBRANE CURRENTS IN ISOLATED HUMAN DETRUSOR SMOOTH-MUSCLE CELLS [J].
MONTGOMERY, BSI ;
FRY, CH .
JOURNAL OF UROLOGY, 1992, 147 (01) :176-184
[66]   Muscarinic M2 receptors inhibit Ca2+-activated K+ channels in rat bladder smooth muscle [J].
Nakamura, T ;
Kimura, J ;
Yamaguchi, O .
INTERNATIONAL JOURNAL OF UROLOGY, 2002, 9 (12) :689-696
[67]  
NORONHABLOB L, 1991, J PHARMACOL EXP THER, V256, P562
[68]   Urge incontinence - Quality of life and patients' valuation of symptom reduction [J].
O'Conor, RM ;
Johannesson, M ;
Hass, SL ;
Kobelt-Nguyen, G .
PHARMACOECONOMICS, 1998, 14 (05) :531-539
[69]   The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction [J].
Pontari, MA ;
Braverman, AS ;
Ruggieri, MR .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2004, 286 (05) :R874-R880
[70]   A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women [J].
Sand, PK ;
Miklos, J ;
Ritter, H ;
Appell, R .
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2004, 15 (04) :243-248